Licensing (Marketing Authorisation): The MHRA has approved: Semaglutide (Wegovy) for adults with BMI 30 kg/m or BMI 27 kg/m with at least one weight-related comorbidity Liraglutide (Saxenda) with similar BMI criteria NHS Access (NICE Guidance): According to NICE guidance (TA664 for semaglutide), NHS-funded treatment is more restricted and typically available for adults with: BMI 35 kg/m with at least one weight-related comorbidity (such as hypertension, type 2 diabetes, dyslipidaemia, obstructive sleep apnoea, or cardiovascular disease) For individuals from Black, Asian, and minority ethnic backgrounds, lower BMI thresholds may apply, recognising that these populations face increased metabolic risk at lower BMI levels
Discover a New Level of Wellness and Beauty At SkyBalance, we blend the serene environment of a spa with the precision and innovation of medical science
Some people tolerate Ozempic better, others prefer Mounjaro
Product Specifications Product Name: APLB Glutathione Niacinamide Facial Cream Size: 55ml Skin Type: All skin types Texture: Lightweight lotion-like moisturizing cream Main Ingredients: Glutathione Niacinamide Centella Asiatica Extract Adenosine Sodium Hyaluronate Shea Butter Macadamia Seed Oil Hydrolyzed Collagen Beta-Glucan Squalane Primary Benefits: Brightening Deep hydration Anti-aging care Barrier strengthening Soothing Improved elasticity Frequently Asked Questions Is APLB Glutathione Niacinamide Facial Cream suitable for daily use
